Race In Medicine: A Dangerous Prescription




A DVD of our latest Race In Medicine panel is available for purchase here. For a detailed description of the event please see below. Along with the purchase comes a limited license to screen this DVD for educational purposes in a classroom or theatrical event. Broadcasting or sharing over telecommunication devices is not permitted. Quantities are limited. Cost includes shipping and handling. Please allow up to four weeks for delivery.


Program highlights:

  • Panel discussion of effect race has on healthcare
  • Industry experts and activists presenting current state of healthcare
  • Q&A with panelists


Major topics included:

  • History of Bidil, the first drug approved with a racial indication of use
  • Marketing of drugs based on racial predisposition to disease
  • Race as biology vs. social construct
  • Marrow donation
  • Treatment of multiracial people in medicine: hybrid vigor vs. hybrid degeneracy


This program was initially presented at the 2010 Critical Mixed Race Studies conference at DePaul University as “Rx For the FDA.” The audio of this panel may be found on iTunes University. The panel was reprised in 2012 as “Race In Medicine” in partnership with the Mixed Student Union of UCLA.

Past panelists and moderator were:

  • Dorothy Roberts, J.D., Kirkland & Ellis Professor, Northwestern University Law School, Professor, Department of African-American Studies and Sociology, Faculty Fellow, Institute for Policy Research

Dorothy Roberts, JD has written and lectured extensively on the interplay of gender, race, and class in legal issues concerning reproduction, bioethics, and child welfare. She is the author of Killing the Black Body: Race, Reproduction, and the Meaning of Liberty (Pantheon, 1997). She is also the co-editor of Sex, Power and Taboo: Gender and HIV in the Caribbean and Beyond, as well as casebooks on constitutional law and women and the law and has published more than 70 articles and essays in books and scholarly journals. Her most recent book is Fatal Invention: How Science, Politics, and Big Business Re-create Race in the Twenty-first Century (The New Press, 2011). She serves on the board of directors of the Black Women’s Health Imperative, the National Coalition for Child Protection Reform, and Generations Ahead, as well as on the executive committee of Cells to Society: The Center on Social Disparities and Health at IPR. She also serves on a panel of five national experts that is overseeing foster care reform in Washington State and on the Standards Working Group of the California Institute for Regenerative Medicine.

  • Michael Hodgson, Cambridge BioMarketing

Michael Hodgson has over 15 years’ experience in pharmaceutical and biotechnology marketing communications to doctors and patients across multiple therapeutic categories including neurology, hematology, nephrology, and orphan diseases. Trained as a copywriter, he now serves as a partner and creative director of Cambridge BioMarketing, a Boston-based communications agency with clients that include Biogen, Genzyme, and Novartis Pharmaceuticals. Mike received a BA in English at the University of California, Berkeley.

  • Athena Mari Asklipiadis, Founder, Mixed Marrow

Athena Mari Asklipiadis, Japanese, Greek, Armenian, Italian, and Egyptian, was born and raised in Los Angeles, California.  She is a graduate of Pepperdine University with a bachelor’s degree in broadcasting.  In 2002, she first stepped onto the multiracial/multiethnic scene by writing for Eurasian Nation.  Athena worked in radio production and promotions for CBS and Clear Channel in Los Angeles as well as a freelance voiceover actor and as a site leader for WeAreHapa.com where she is now Community Manager.

In 2008, Athena recognized the need for multiethnic donors in the national bone marrow registry and in 2009, she started Mixed Marrow as an outreach through A3M and Be The Match, the national registry.  Mixed Marrow serves to not only educate the public about the need for multiethnic marrow and cord blood, but also register people at bone marrow drives across the country.  She is a member of MASC and JAO, Japanese American Optimists.

  • G. Reginald Daniel, PhD, Professor, Department of Sociology, University of California, Santa Barbara.

Since 1989, G. Reginald Daniel, PhD has taught “Betwixt and Between,” which is one of the first and longest-standing university courses to deal specifically with the question of multiracial identity comparing the U.S. with various parts of the world.  He has published numerous articles and chapters that cover this topic.  His books entitled More Than Black? Multiracial Identity and the New Racial Order (2002) and Race and Multiraciality in Brazil and the United States: Converging Paths? (2006), and his article “Race, Multiraciality, and Barack Obama: Toward a More Perfect Union?” are a culmination of much of this thinking on the relationship between social structure and racial formation–especially multiracial identities.  He is a member of the Advisory Board of Association of Multiethnic Americans (AMEA), Advisory Council of the Mixed Heritage Center of MAVIN Foundation, and Advisory Board of Multiracial Americans of Southern California (MASC).

  • Moderator: Thomas Lopez, Board Member, MASC

Thomas Lopez has been a member of MASC for over fifteen years and is a past president of the organization.  He has made numerous television, print, and on-line media appearances and speaking engagements as a keynote and panelist.  As a long-time board member he has also organized conferences, a mini-film festival, and diversity training workshops.  Apart from MASC, Thomas holds a BS in Mechanical Engineering from UC Berkeley and has worked in multiple industries the most recent being Boston Scientific, a leading medical device manufacturer.  He resides in Southern California and hails from Mexican American and German/Polish roots.




There are no reviews yet.

Be the first to review “Race In Medicine: A Dangerous Prescription”

Your email address will not be published. Required fields are marked *

Post comment